CAS No.79559-97-0,Sertraline HCL Suppliers

Products Categories

Pharmaceutical (215)
Others (66)
Organic Chemicals (35)
Reagent (7)
Plant Extract (3)
(3)
Materials (2)
Dyestuff and Pigment (1)

Basic Information

Molecular Structure:
CAS No.:	79559-97-0
Name:	Sertraline HCL
Article Data:	33

Formula:	C₁₇H₁₇Cl₂N.HCl
Molecular Weight:	342.696
Synonyms:	1-Naphthalenamine,4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S,4S)-(9CI);(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenaminehydrochloride;(1S,4S)-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenaminehydrochloride;Altruline;Aremis;Atruline;Cp 51974-1;Dominum;Gladem;Lesefer;Lustral;Selectra;Sosser;Stimuloton;Zolof;Zoloft;
EINECS:	200-659-6
Density:	1.37
Melting Point:	246-249 °C
Boiling Point:	416.3 °C at 760 mmHg
Flash Point:	205.6 °C
Solubility:	DMSO: ~26 mg/mL
Appearance:	White or white-like crystalline powder
Hazard Symbols:	Xi
Risk Codes:	36/37/38
Safety:	22-24/25-36-26
PSA:	12.03000
LogP:	6.37250

Synthetic route

: sertraline 4-methoxybenzoate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In diethyl ether; nitromethane at 25 - 30℃; for 1h; Product distribution / selectivity;	97%

: 79617-96-2
Sertraline

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In propan-1-ol at 30℃; for 1h; Product distribution / selectivity;	96%
With hydrogenchloride In acetonitrile for 1h; Product distribution / selectivity;	95%
With hydrogenchloride In octanol for 1h; Product distribution / selectivity;	95%

: 836597-67-2
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphtalenamine citrate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In acetonitrile at 20℃; for 1h; Product distribution / selectivity;	95%
With hydrogenchloride In propan-1-ol; water at 20 - 70℃; for 1h; pH=0; Product distribution / selectivity;	90%

(1S-cis)-4-(3,4 dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine mandelate: (1S-cis)-4-(3,4 dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine mandelate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In methoxypropyl acetate at 20 - 70℃; for 3h; Product distribution / selectivity;	95%
With N,N-dimethylacetamide hydrochloride In 4-methyl-2-pentanone at 20 - 80℃; for 1.5h; Product distribution / selectivity;	94%
With N,N-dimethylacetamide hydrochloride In acetonitrile at 20℃; for 1h; Product distribution / selectivity;	90%

: 928057-23-2
sertraline adipate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In diethyl ether; nitromethane at 25 - 30℃; for 1h; Product distribution / selectivity;	86%

: 244223-89-0, 79617-97-3
(cis-1S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine (R)-mandelate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With sodium hydroxide In dichloromethane; water Industrial scale;	85%
With hydrogenchloride In acetonitrile at 0 - 15℃; for 0.5 - 1h; Product distribution / selectivity;	82.6%
With hydrogenchloride In tert-Amyl alcohol at 25 - 30℃; for 8h; pH=2.0; Product distribution / selectivity;

: C17H17Cl2N*C5H9NO4

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
Stage #1: C17H17Cl2N*C5H9NO4 With sodium hydroxide In water; toluene at 80℃; for 3h; Stage #2: With hydrogenchloride In ethanol pH=1.0; Heating;	83.68%

: 928057-20-9
sertraline phthalate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In diethyl ether; 4-methyl-2-pentanone at 25 - 70℃; for 3h; Product distribution / selectivity;	79%

: 928057-24-3
sertraline 4-methylbenzoate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In diethyl ether; nitromethane at 25 - 30℃; for 1h; Product distribution / selectivity;	79%

: 928057-22-1
sertraline salicylate

: 79559-97-0
sertraline hydrochloride

Conditions

Conditions	Yield
With hydrogenchloride In diethyl ether; nitromethane at 25 - 30℃; for 1h; Product distribution / selectivity;	73%

Raw Materials

64-19-7

79560-19-3

95-50-1

90-15-3

7647-01-0

79617-96-2

Downstream Products

79617-96-2

Total:224 Page 1 of 6 1 2 3 4 5 6 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 79559-97-0

Specification

The Sertraline hydrochloride with the cas number 79559-97-0, is also called (1)(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthylamine hydrochloride; (2) Adjuvin ; (3) Atruline ; (4) Gladem ; (5) Serad ; (6) Sertraline HCl ; (7) Sertraline hydrochloride ; (8) Tatig ; (9) Tresleen ; (10) Zoloft ; (11)1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S-cis)- . It belongs to the following product categories:(1)Pharmaceutical Intermediates; (2)Active PharmaceuticalIngredients; (3)APIs; (4)Inhibitors; (5)Intermediates & Fine Chemicals; (6)Pharmaceuticals; (7)Serotonin receptor

Properties of Sertraline hydrochloride are: (1)ACD/LogP: 4.81 ; (2)# of Rule of 5 Violations: 0 ; (3)ACD/LogD (pH 5.5): 1.77 ; (4)ACD/LogD (pH 7.4): 2.77 ; (5)ACD/BCF (pH 5.5): 2.41 ; (6)ACD/BCF (pH 7.4): 24.52 ; (7)ACD/KOC (pH 5.5): 8.89 ; (8)ACD/KOC (pH 7.4): 90.64 ; (9)#H bond acceptors: 1 ; (10)#H bond donors: 1 ; (11)#Freely Rotating Bonds: 2 ; (12)Polar Surface Area: 3.24Å² ; (13)Flash Point: 205.6 °C ; (14)Enthalpy of Vaporization: 66.96 kJ/mol; (15)Boiling Point: 416.3 °C at 760 mmHg ; (16)Vapour Pressure: 3.85E-07 mmHg at 25°C

The Sertraline hydrochloride appears to be white or white-like crystalline powder. The Sertraline hydrochloride is mainly used for treatment with depression and obsessive-compulsive disorder. Usage and dosage: The usual dose is 50mg, once a day. Dose can be increased according to patient's condition within weeks, the maximum amount can reach 200mg/day. Please pay attention to using this medicine, because it can cause the following adverse effects: slight xerocheilia, nausea, indigestion, liquid stools and diarrhea. A few patients may show tremor, sweating, defering male ejaculation. Serum transaminase occasionally asymptomatically increase.

You can still convert the following datas into molecular structure :
1. SMILES: Cl.Clc1ccc(cc1Cl)[C@H]3c2c(cccc2)[C@@H](NC)CC3
2. InChI: InChI=1/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/m0./s1

The Sertraline hydrochloride toxic data can be showed in the following sheet.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
man	TDLo	oral	2857ug/kg (2.857mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" GASTROINTESTINAL: NAUSEA OR VOMITING SKIN AND APPENDAGES (SKIN): SWEATING: OTHER	Shinkei Seishin Yakuri. Neuropsychopharmacology. Vol. 19, Pg. 395, 1997.
mouse	LDLo	intraperitoneal	56mg/kg (56mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: FOOD INTAKE (ANIMAL)	Drug and Chemical Toxicology. Vol. 21, Pg. 163, 1998.
mouse	LDLo	oral	336mg/kg (336mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: FOOD INTAKE (ANIMAL)	Drug and Chemical Toxicology. Vol. 21, Pg. 163, 1998.
rat	LDLo	intraperitoneal	56mg/kg (56mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: FOOD INTAKE (ANIMAL)	Drug and Chemical Toxicology. Vol. 21, Pg. 163, 1998.
rat	LDLo	oral	840mg/kg (840mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: FOOD INTAKE (ANIMAL) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	Drug and Chemical Toxicology. Vol. 21, Pg. 163, 1998.
women	TDLo	oral	7mg/kg/2W-I (7mg/kg)	BEHAVIORAL: HEADACHE MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES SKIN AND APPENDAGES (SKIN): SWEATING: OTHER	Journal of Clinical Psychiatry. Vol. 54, Pg. 432, 1993.
women	TDLo	oral	7mg/kg/7D-I (7mg/kg)	BEHAVIORAL: EXCITEMENT	Journal of Clinical Psychiatry. Vol. 54, Pg. 321, 1993.